Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1593, 2007-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
KRAS status predicts response to cetuximab in mCRC
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Access to resources
Recommend
Cetuximab launched for mCRC, approved for SCCHN.
Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. :
Cetuximab extends survival in patients with mCRC
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Bevacizumab gives a boost to chemotherapeutics in mCRC
Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. :
Picoplatin promising as treatment for both mCRC and HRPC
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :